Eton Pharmaceuticals, Inc.
Prognozy (mln)
| Okres |
2024-12-31 |
2025-12-31 |
2026-12-31 |
2027-12-31 |
2028-12-31 |
2029-12-31 |
| Przychód (średnia) |
37.91 |
76.92 |
112.08 |
156.71 |
197.08 |
231.17 |
| Przychód Δ r/r |
0.00% |
102.92% |
45.71% |
39.82% |
25.76% |
17.30% |
| Przychód (min) |
37.81 |
59.96 |
106.93 |
141.67 |
178.16 |
208.98 |
| Przychód (max) |
38.01 |
93.87 |
121.90 |
174.51 |
219.46 |
257.42 |
| EBITDA (średnia) |
-10.64 |
-21.58 |
-31.45 |
-43.97 |
-55.30 |
-64.87 |
| EBIT (średnia) |
-11.86 |
-24.07 |
-35.07 |
-49.03 |
-61.66 |
-72.33 |
| EBIT % |
-31.29% |
-31.29% |
-31.29% |
-31.29% |
-31.29% |
-31.29% |
| Zysk netto (średni) |
-3.28 |
11.22 |
32.28 |
49.12 |
67.97 |
82.86 |
| Zysk netto % |
-8.65% |
14.59% |
28.80% |
31.34% |
34.49% |
35.84% |
| EPS (średnia) |
-0.13 |
0.43 |
1.25 |
1.82 |
2.62 |
3.20 |
| Liczba analityków (Przychody) |
2 |
2 |
3 |
2 |
1 |
1 |
| Liczba analityków (EPS) |
2 |
2 |
3 |
2 |
1 |
1 |
| symbol |
ETON |
ETON |
ETON |
ETON |
ETON |
ETON |